Krajina Z, Kosoković F, Bolanca S
Acta Otolaryngol. 1979 Mar-Apr;87(3-4):388-92. doi: 10.3109/00016487909126438.
The authors carried out immunological investigations in 96 patients with laryngeal cancer. The following tests were applied: DNCB, PPD, phyto-test and the lymphocyte count. The patients were divided into three groups: 1) cured, one year following treatment; 2) relapses; 3) died during the first year. The separate group of 13 patients tested twice in first year was analysed too. The immunological tests were also performed in 24 patients with no relapses of laryngeal cancer in the period between 3 and 10 years after treatment. This group was used for a comparative analysis with laryngeal relapses. In our opinion each individual test has its relative merit. According to our results patients with normal and elevated test values have the best prognosis of cancer disease.
作者对96例喉癌患者进行了免疫学研究。采用了以下检测方法:二硝基氯苯(DNCB)、结核菌素纯蛋白衍生物(PPD)、植物血凝素试验和淋巴细胞计数。患者被分为三组:1)治疗后一年治愈;2)复发;3)在第一年死亡。对第一年进行了两次检测的13名患者单独分组也进行了分析。还对24例治疗后3至10年间无喉癌复发的患者进行了免疫学检测。该组用于与喉癌复发患者进行对比分析。我们认为每项单独的检测都有其相对优点。根据我们的结果,检测值正常和升高的患者癌症疾病预后最佳。